Report Presents U.S. Trends in Abortion Methods, Care

Share this content:
Report Presents U.S. Trends in Abortion Methods, Care
Report Presents U.S. Trends in Abortion Methods, Care

WEDNESDAY, March 21, 2018 (HealthDay News) -- The percentage of abortions performed by the medication method is increasing, and most abortions are performed in a non-hospital setting, according to a report published by the National Academy of Sciences, Engineering, and Medicine.

B. Ned Calonge, M.D., Ph.D., from the University of Colorado Denver, and colleagues examined the scientific evidence on the safety and quality of four abortion methods used in the United States: medication, aspiration, dilation and evacuation, and induction.

The researchers note that there was a considerable decrease in the abortion rate in U.S. women between 1980 and 2014. The most common abortion method is aspiration, which accounted for almost 68 percent of abortions performed in 2013. From 2004 to 2013, there was an increase in the percentage of total abortions by the medication method, from 10.6 to 22.3 percent. Most abortions performed in 2014 were performed in non-hospital settings; less than 5 percent were provided in hospitals. The number of facilities providing abortions is declining, with the greatest decrease in states that have enacted abortion-specific regulations. In 2014, there were 17 percent fewer abortion clinics than in 2011, and 39 percent of women of reproductive age resided in a county without an abortion provider.

"This report provides a comprehensive review of the state of the science on the safety and quality of abortion services in the United States," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Cap'n Crunch Cereal Recalled Due to Salmonella Scare

Cap'n Crunch Cereal Recalled Due to <i>Salmonella</i> Scare

No illnesses related to the products have been reported to date

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

FDA Approves First-Line Tx for Peripheral T-Cell Lymphoma

Adcetris approved in combination with chemo to treat systemic anaplastic large cell lymphoma

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

FDA Warns Against Giving Honey-Filled Pacifiers to Infants

Four infants in Texas hospitalized with botulism after using pacifiers containing honey

is free, fast, and customized just for you!




Already a member?

Sign In Now »